OSTİM Technical University Library

Sepetiniz boş.

Diseases of the Chest, Breast, Heart and Vessels 2019-2022 : Diagnostic and Interventional Imaging.

Yazar:Hodler, Juerg
Katkıda bulunan(lar):Kubik-Huch, Rahel A | von Schulthess, , Gustav K | Hodler, Juerg | Kubik-Huch, Rahel A | von Schulthess, , Gustav K
Materyal türü: KonuKonuSeri kaydı: Yayıncı: Cham : Springer International Publishing AG, 2019Telif hakkı tarihi: �2019Tanım: 1 online resource (237 pages)İçerik türü:text Ortam türü:computer Taşıyıcı türü: online resourceISBN: 9783030111496Tür/Form:Electronic books.Ek fiziksel biçimler:Print version:: Diseases of the Chest, Breast, Heart and Vessels 2019-2022LOC classification: R895-920Çevrimiçi kaynaklar: Click to View
İçindekiler:
Intro -- Preface -- Contents -- 1: A Systematic Approach to Chest Radiographic Analysis -- 1.1 Introduction -- 1.2 A Systematic Assessment -- 1.3 Technical Quality (Table 1.2) -- 1.4 Support/Monitoring Devices (Tubes/Lines/Catheters/Pacemakers) (Table 1.3) [2] -- 1.5 Chest Wall -- 1.6 Mediastinum -- 1.6.1 Heart -- 1.6.2 Systemic Arteries -- 1.6.3 Systemic Veins -- 1.6.4 Pulmonary Arteries -- 1.6.5 Lines, Stripes, and Interfaces [5] -- 1.6.6 Mediastinal Masses (Table 1.5) [6] -- 1.6.7 Mediastinal Calcification -- 1.6.8 Pneumomediastinum -- 1.7 Hila -- 1.8 Lungs -- 1.8.1 Lung Volumes -- 1.8.2 Parenchymal Opacities -- 1.9 Airways -- 1.10 Pleura/Diaphragm -- 1.11 Concluding Remarks -- References -- 2: Missed Lung Lesions: Side-by-Side Comparison of Chest Radiography with MDCT -- 2.1 Introduction -- 2.2 Reasons for Missed Lung Lesions -- 2.3 Specific Problems -- 2.4 Missed Nodules -- 2.4.1 Nodular Lesions: Tumours -- 2.4.2 Nodular Lesions: Infections -- 2.5 Missed Consolidation -- 2.5.1 Airspace Disease -- 2.6 Missed Interstitial Lung Disease -- 2.6.1 Diffuse (Interstitial or Mixed Alveolar-Interstitial) Lung Disease -- 2.7 Key Signs for Reducing the Risk of Errors in CXRs -- 2.7.1 Deep Sulcus Sign -- 2.7.2 Spine Sign -- 2.7.3 Silhouette Sign -- 2.8 Concluding Remarks -- References -- 3: Approach to Imaging of Mediastinal Conditions in the Adult -- 3.1 Introduction -- 3.2 Anterior Mediastinum/Prevascular Compartment -- 3.3 Middle Mediastinum/Visceral Compartment -- 3.4 Posterior Mediastinum/Paravertebral Compartment -- 3.5 Conditions that Disregard the Compartment Model -- 3.6 Conclusion -- Suggested Readings -- 4: Plain Film and HRCT Diagnosis of Interstitial Lung Disease -- 4.1 The HRCT Technique -- 4.2 HRCT in Diffuse Interstitial Lung Disease -- 4.3 An Approach to HRCT Diagnoses.
4.3.1 Is There a "Real" Abnormality? -- 4.3.2 If There Is An Abnormality, What Is/Are the Predominant HRCT Pattern(s)? -- 4.3.3 What Is the Distribution of Disease? -- 4.3.4 Are There Any Ancillary Findings? -- 4.3.5 What Is the Likely Pathology? -- 4.3.6 What Is the Clinical Background? -- 4.4 HRCT Appearances in Select DILDs -- 4.4.1 Usual Interstitial Pneumonia/Idiopathic Pulmonary Fibrosis -- 4.4.2 (Cryptogenic) Organizing Pneumonia -- 4.4.3 Non-specific Interstitial Pneumonia -- 4.4.4 Smoking-Related Lung Diseases -- 4.4.5 Sarcoidosis -- 4.4.6 Hypersensitivity Pneumonitis -- 4.5 Concluding Remarks -- References -- 5: CT Diagnosis and Management of Focal Lung Disease -- 5.1 Benign Solid Nodule Features -- 5.2 Malignant Solid Nodule Features -- 5.3 Subsolid Nodules -- 5.4 Indeterminate Pulmonary Nodules -- 5.5 Role of Computer-Assisted Diagnosis for Solid Nodules -- 5.6 Focal Parenchymal Airspace Disease -- 5.7 Dual-Energy CT (DECT) -- References -- 6: Current Approach to Acute and Chronic Airway Disease -- 6.1 CT Acquisition and Post-processing Techniques [1, 2] -- 6.2 Tracheobronchial Tumours (Tables 6.1, 6.2, 6.3, and 6.4) [3-6] -- 6.2.1 Primary Malignant Neoplasms -- 6.2.2 Secondary Tracheobronchial Malignancy -- 6.2.3 Benign Tracheobronchial Neoplasms -- 6.3 Nonneoplastic Tracheobronchial Disorders (Tables 6.2, 6.3, and 6.4) [4, 5, 7] -- 6.3.1 Posttraumatic Stenosis -- 6.3.2 Infections -- 6.3.3 Granulomatosis with Polyangiitis (Wegener Granulomatosis) -- 6.3.4 Relapsing Polychondritis -- 6.3.5 Amyloidosis -- 6.3.6 Tracheobronchopathia Osteochondroplastica (TO) -- 6.3.7 Sabre-Sheath Trachea -- 6.3.8 Tracheobronchomegaly (Mounier-Kuhn Syndrome) -- 6.3.9 Tracheobronchomalacia and Excessive Dynamic Airway Collapse [8, 9, 10] -- 6.3.10 Broncholithiasis.
6.4 Tracheobronchial Fistula, Dehiscence, and Diverticula (Table 6.5) [2, 11] -- 6.5 Bronchiectasis [12, 13] -- 6.6 Small Airway Diseases [2, 16] -- 6.6.1 Small Centrilobular Nodular and Branching Linear Opacities (Tree-in-Bud) -- 6.6.2 Poorly Defined Centrilobular Nodules -- 6.6.3 Decreased Lung Attenuation and Mosaic Perfusion -- 6.6.4 Expiratory Air Trapping -- 6.7 Constrictive (Obliterative) Bronchiolitis [2, 16] -- 6.8 Asthma [17] -- 6.9 Airway Disease in COPD [19] -- 6.10 Concluding Remarks -- References -- 7: Imaging of Pulmonary Infection -- 7.1 Community-Acquired Pneumonia (CAP) -- 7.1.1 Radiographic Patterns of CAP -- 7.2 Hospital-Acquired Pneumonia (HAP) -- 7.3 Ventilator-Associated Pneumonia (VAP) -- 7.4 Healthcare-Associated Pneumonia (HCAP) -- 7.5 Clinical Utility and Limitations of Chest Radiography and CT -- 7.5.1 Chest Radiography -- 7.5.2 Computed Tomography -- 7.6 Patterns of Pulmonary Infection -- 7.7 Aerobic Bacteria -- 7.7.1 Gram-Positive Cocci -- 7.7.1.1 Streptococcus Pneumoniae -- 7.7.1.2 Staphylococcus aureus -- 7.7.2 Gram-Positive Bacilli -- 7.7.2.1 Actinomycosis -- 7.7.2.2 Nocardia Species -- 7.7.3 Gram-Negative Bacilli -- 7.7.3.1 Klebsiella -- 7.7.3.2 Escherichia coli -- 7.7.3.3 Pseudomonas aeruginosa -- 7.7.3.4 Chlamydia -- 7.7.3.5 Rickettsial Pneumonia -- 7.7.3.6 Francisella tularensis -- 7.7.4 Gram-Negative Coccobacilli -- 7.7.4.1 Haemophilus influenza -- 7.7.4.2 Legionella Species -- 7.7.5 Gram-Negative Cocci -- 7.7.5.1 Moraxella catarrhalis -- 7.8 Miscellaneous Infections -- 7.8.1 Mycoplasma pneumoniae -- 7.9 Mycobacteria -- 7.9.1 Mycobacterium Tuberculosis -- 7.9.1.1 Primary tuberculosis -- 7.9.1.2 Postprimary tuberculosis -- 7.9.1.3 Pulmonary Nontuberculous Mycobacteria (NTMB) -- 7.10 Fungal Infections -- 7.10.1 Aspergillus Infection -- 7.10.2 Candidiasis.
7.10.3 Pneumocystis jiroveci -- 7.10.4 Mucormycosis -- 7.11 Viral Pneumonias -- 7.11.1 Influenza a -- 7.11.2 Adenovirus -- 7.11.3 Respiratory Syncytial Virus (RSV) -- 7.11.4 Epstein-Barr Virus (EBV) -- 7.11.5 Varicella Virus -- 7.11.6 Cytomegalovirus (CMV) -- 7.12 New Emerging Viruses -- 7.12.1 Severe Acute Respiratory Distress Syndrome (SARS) -- 7.12.2 Middle East Respiratory Syndrome (MERS) -- 7.12.3 Swine Influenza (H1N1) -- References -- 8: Current Concepts in the Diagnosis and Staging of Lung Cancer -- 8.1 Introduction -- 8.2 Diagnosis of Lung Cancer -- 8.2.1 Clinical Symptoms -- 8.2.2 Imaging Evaluation of Pulmonary Nodules -- 8.2.2.1 Morphology and Density -- 8.2.2.2 Growth -- 8.2.2.3 Metabolic Activity -- 8.3 Patient Evaluation and the Role of Imaging -- 8.3.1 Computed Tomography -- 8.3.2 FDG PET/CT -- 8.3.3 MR Imaging -- 8.4 Lung Cancer Staging -- 8.4.1 Rationale and Methodology for TNM-8 -- 8.4.2 Modifications to TNM-8 -- 8.4.2.1 T Classification -- 8.4.2.2 Tumor Size -- 8.4.2.3 Involvement of Main Bronchi -- 8.4.2.4 Atelectasis or Pneumonitis of the Lung -- 8.4.2.5 Diaphragmatic Invasion -- 8.4.2.6 Involvement of the Mediastinal Pleura -- 8.4.2.7 Lymph Node (N) Classification -- 8.4.2.8 Metastasis (M) Classification -- 8.4.3 Stage Groups -- 8.4.4 Lung Cancers with Multiple Sites of Pulmonary Involvement -- 8.4.4.1 Multiple Primary Lung Cancers -- 8.4.4.2 Lung Cancer with One or More Tumor Nodules -- 8.4.4.3 Multiple Ground-glass Lesions -- 8.4.4.4 Consolidation -- 8.4.5 Tumor Measurement -- 8.4.6 Small Cell Lung Cancer -- 8.5 Concluding Remarks -- References -- 9: Diseases of the Chest Wall, Pleura, and Diaphragm -- 9.1 Introduction -- 9.2 Chest Wall Disease -- 9.3 Hyperlucent or Hyperopaque Hemithorax -- 9.4 Soft Tissue Masses -- 9.5 Inflammatory Disease of the Chest Wall.
9.6 Calcification -- 9.6.1 Pectus Excavatum -- 9.6.2 Injuries to the Thoracic Skeleton/Rib Fractures/Trauma -- 9.7 Thalassaemia -- 9.8 Pleural Disease -- 9.9 Pleural Effusion -- 9.10 Empyema -- 9.11 Pneumothorax -- 9.12 Hemothorax -- 9.13 Pleural Plaques or Thickening -- 9.14 Pleural Implants and Masses -- 9.15 Diaphragmatic Disease -- 9.16 Bochdalek Hernia -- 9.17 Morgagni Hernia -- 9.18 Diaphragmatic Eventration -- 9.19 Esophageal hiatus hernia -- 9.20 Blunt Traumatic Diaphragmatic Rupture -- 9.21 Penetrating Diaphragmatic Injury -- 9.22 Diaphragmatic Paresis or Paralysis -- 9.23 Tumors of the Diaphragm -- 9.24 Conclusion -- References -- 10: Pediatric Chest Disorders: Practical Imaging Approach to Diagnosis -- 10.1 Introduction -- 10.2 Advantages and Disadvantages of Imaging Modalities -- 10.2.1 Chest Radiography -- 10.2.2 Computed Tomography -- 10.2.3 Magnetic Resonance Imaging -- 10.3 Spectrum of Pediatric Thoracic Disorders -- 10.3.1 Pediatric Lung Disorders -- 10.3.1.1 Neonatal Lung Disorders -- Surfactant Deficiency Syndrome due to Prematurity -- Congenital Surfactant Deficiency -- Transient Tachypnea of Newborn -- Meconium Aspiration -- Neonatal Pneumonia -- 10.3.1.2 Pulmonary Infection in Children -- Round Pneumonia -- 10.3.2 Pediatric Large Airway Disorders -- 10.3.2.1 Large Airway Neoplasms -- Subglottic Hemangioma -- Carcinoid Tumor -- 10.3.2.2 Nonneoplastic Disorders of the Large Airway -- Tracheomalacia -- Foreign Body Aspiration -- 10.3.3 Pediatric Mediastinal Disorders -- 10.3.3.1 Vascular Lesions -- Double Aortic Arch -- Right Aortic Arch -- Pulmonary Artery Sling -- 10.3.3.2 Nonvascular Lesions -- Foregut Duplication Cyst -- Neuroblastoma -- Lymphatic Malformation -- 10.4 Conclusion -- References -- 11: Pulmonary Manifestations of Systemic Diseases -- 11.1 Introduction -- 11.2 Sarcoidosis.
11.3 Connective Tissue Disease.
Bu kütüphanenin etiketleri: Kütüphanedeki eser adı için etiket yok. Etiket eklemek için oturumu açın.
    Ortalama derecelendirme: 0.0 (0 oy)
Bu kayda ilişkin materyal yok

Intro -- Preface -- Contents -- 1: A Systematic Approach to Chest Radiographic Analysis -- 1.1 Introduction -- 1.2 A Systematic Assessment -- 1.3 Technical Quality (Table 1.2) -- 1.4 Support/Monitoring Devices (Tubes/Lines/Catheters/Pacemakers) (Table 1.3) [2] -- 1.5 Chest Wall -- 1.6 Mediastinum -- 1.6.1 Heart -- 1.6.2 Systemic Arteries -- 1.6.3 Systemic Veins -- 1.6.4 Pulmonary Arteries -- 1.6.5 Lines, Stripes, and Interfaces [5] -- 1.6.6 Mediastinal Masses (Table 1.5) [6] -- 1.6.7 Mediastinal Calcification -- 1.6.8 Pneumomediastinum -- 1.7 Hila -- 1.8 Lungs -- 1.8.1 Lung Volumes -- 1.8.2 Parenchymal Opacities -- 1.9 Airways -- 1.10 Pleura/Diaphragm -- 1.11 Concluding Remarks -- References -- 2: Missed Lung Lesions: Side-by-Side Comparison of Chest Radiography with MDCT -- 2.1 Introduction -- 2.2 Reasons for Missed Lung Lesions -- 2.3 Specific Problems -- 2.4 Missed Nodules -- 2.4.1 Nodular Lesions: Tumours -- 2.4.2 Nodular Lesions: Infections -- 2.5 Missed Consolidation -- 2.5.1 Airspace Disease -- 2.6 Missed Interstitial Lung Disease -- 2.6.1 Diffuse (Interstitial or Mixed Alveolar-Interstitial) Lung Disease -- 2.7 Key Signs for Reducing the Risk of Errors in CXRs -- 2.7.1 Deep Sulcus Sign -- 2.7.2 Spine Sign -- 2.7.3 Silhouette Sign -- 2.8 Concluding Remarks -- References -- 3: Approach to Imaging of Mediastinal Conditions in the Adult -- 3.1 Introduction -- 3.2 Anterior Mediastinum/Prevascular Compartment -- 3.3 Middle Mediastinum/Visceral Compartment -- 3.4 Posterior Mediastinum/Paravertebral Compartment -- 3.5 Conditions that Disregard the Compartment Model -- 3.6 Conclusion -- Suggested Readings -- 4: Plain Film and HRCT Diagnosis of Interstitial Lung Disease -- 4.1 The HRCT Technique -- 4.2 HRCT in Diffuse Interstitial Lung Disease -- 4.3 An Approach to HRCT Diagnoses.

4.3.1 Is There a "Real" Abnormality? -- 4.3.2 If There Is An Abnormality, What Is/Are the Predominant HRCT Pattern(s)? -- 4.3.3 What Is the Distribution of Disease? -- 4.3.4 Are There Any Ancillary Findings? -- 4.3.5 What Is the Likely Pathology? -- 4.3.6 What Is the Clinical Background? -- 4.4 HRCT Appearances in Select DILDs -- 4.4.1 Usual Interstitial Pneumonia/Idiopathic Pulmonary Fibrosis -- 4.4.2 (Cryptogenic) Organizing Pneumonia -- 4.4.3 Non-specific Interstitial Pneumonia -- 4.4.4 Smoking-Related Lung Diseases -- 4.4.5 Sarcoidosis -- 4.4.6 Hypersensitivity Pneumonitis -- 4.5 Concluding Remarks -- References -- 5: CT Diagnosis and Management of Focal Lung Disease -- 5.1 Benign Solid Nodule Features -- 5.2 Malignant Solid Nodule Features -- 5.3 Subsolid Nodules -- 5.4 Indeterminate Pulmonary Nodules -- 5.5 Role of Computer-Assisted Diagnosis for Solid Nodules -- 5.6 Focal Parenchymal Airspace Disease -- 5.7 Dual-Energy CT (DECT) -- References -- 6: Current Approach to Acute and Chronic Airway Disease -- 6.1 CT Acquisition and Post-processing Techniques [1, 2] -- 6.2 Tracheobronchial Tumours (Tables 6.1, 6.2, 6.3, and 6.4) [3-6] -- 6.2.1 Primary Malignant Neoplasms -- 6.2.2 Secondary Tracheobronchial Malignancy -- 6.2.3 Benign Tracheobronchial Neoplasms -- 6.3 Nonneoplastic Tracheobronchial Disorders (Tables 6.2, 6.3, and 6.4) [4, 5, 7] -- 6.3.1 Posttraumatic Stenosis -- 6.3.2 Infections -- 6.3.3 Granulomatosis with Polyangiitis (Wegener Granulomatosis) -- 6.3.4 Relapsing Polychondritis -- 6.3.5 Amyloidosis -- 6.3.6 Tracheobronchopathia Osteochondroplastica (TO) -- 6.3.7 Sabre-Sheath Trachea -- 6.3.8 Tracheobronchomegaly (Mounier-Kuhn Syndrome) -- 6.3.9 Tracheobronchomalacia and Excessive Dynamic Airway Collapse [8, 9, 10] -- 6.3.10 Broncholithiasis.

6.4 Tracheobronchial Fistula, Dehiscence, and Diverticula (Table 6.5) [2, 11] -- 6.5 Bronchiectasis [12, 13] -- 6.6 Small Airway Diseases [2, 16] -- 6.6.1 Small Centrilobular Nodular and Branching Linear Opacities (Tree-in-Bud) -- 6.6.2 Poorly Defined Centrilobular Nodules -- 6.6.3 Decreased Lung Attenuation and Mosaic Perfusion -- 6.6.4 Expiratory Air Trapping -- 6.7 Constrictive (Obliterative) Bronchiolitis [2, 16] -- 6.8 Asthma [17] -- 6.9 Airway Disease in COPD [19] -- 6.10 Concluding Remarks -- References -- 7: Imaging of Pulmonary Infection -- 7.1 Community-Acquired Pneumonia (CAP) -- 7.1.1 Radiographic Patterns of CAP -- 7.2 Hospital-Acquired Pneumonia (HAP) -- 7.3 Ventilator-Associated Pneumonia (VAP) -- 7.4 Healthcare-Associated Pneumonia (HCAP) -- 7.5 Clinical Utility and Limitations of Chest Radiography and CT -- 7.5.1 Chest Radiography -- 7.5.2 Computed Tomography -- 7.6 Patterns of Pulmonary Infection -- 7.7 Aerobic Bacteria -- 7.7.1 Gram-Positive Cocci -- 7.7.1.1 Streptococcus Pneumoniae -- 7.7.1.2 Staphylococcus aureus -- 7.7.2 Gram-Positive Bacilli -- 7.7.2.1 Actinomycosis -- 7.7.2.2 Nocardia Species -- 7.7.3 Gram-Negative Bacilli -- 7.7.3.1 Klebsiella -- 7.7.3.2 Escherichia coli -- 7.7.3.3 Pseudomonas aeruginosa -- 7.7.3.4 Chlamydia -- 7.7.3.5 Rickettsial Pneumonia -- 7.7.3.6 Francisella tularensis -- 7.7.4 Gram-Negative Coccobacilli -- 7.7.4.1 Haemophilus influenza -- 7.7.4.2 Legionella Species -- 7.7.5 Gram-Negative Cocci -- 7.7.5.1 Moraxella catarrhalis -- 7.8 Miscellaneous Infections -- 7.8.1 Mycoplasma pneumoniae -- 7.9 Mycobacteria -- 7.9.1 Mycobacterium Tuberculosis -- 7.9.1.1 Primary tuberculosis -- 7.9.1.2 Postprimary tuberculosis -- 7.9.1.3 Pulmonary Nontuberculous Mycobacteria (NTMB) -- 7.10 Fungal Infections -- 7.10.1 Aspergillus Infection -- 7.10.2 Candidiasis.

7.10.3 Pneumocystis jiroveci -- 7.10.4 Mucormycosis -- 7.11 Viral Pneumonias -- 7.11.1 Influenza a -- 7.11.2 Adenovirus -- 7.11.3 Respiratory Syncytial Virus (RSV) -- 7.11.4 Epstein-Barr Virus (EBV) -- 7.11.5 Varicella Virus -- 7.11.6 Cytomegalovirus (CMV) -- 7.12 New Emerging Viruses -- 7.12.1 Severe Acute Respiratory Distress Syndrome (SARS) -- 7.12.2 Middle East Respiratory Syndrome (MERS) -- 7.12.3 Swine Influenza (H1N1) -- References -- 8: Current Concepts in the Diagnosis and Staging of Lung Cancer -- 8.1 Introduction -- 8.2 Diagnosis of Lung Cancer -- 8.2.1 Clinical Symptoms -- 8.2.2 Imaging Evaluation of Pulmonary Nodules -- 8.2.2.1 Morphology and Density -- 8.2.2.2 Growth -- 8.2.2.3 Metabolic Activity -- 8.3 Patient Evaluation and the Role of Imaging -- 8.3.1 Computed Tomography -- 8.3.2 FDG PET/CT -- 8.3.3 MR Imaging -- 8.4 Lung Cancer Staging -- 8.4.1 Rationale and Methodology for TNM-8 -- 8.4.2 Modifications to TNM-8 -- 8.4.2.1 T Classification -- 8.4.2.2 Tumor Size -- 8.4.2.3 Involvement of Main Bronchi -- 8.4.2.4 Atelectasis or Pneumonitis of the Lung -- 8.4.2.5 Diaphragmatic Invasion -- 8.4.2.6 Involvement of the Mediastinal Pleura -- 8.4.2.7 Lymph Node (N) Classification -- 8.4.2.8 Metastasis (M) Classification -- 8.4.3 Stage Groups -- 8.4.4 Lung Cancers with Multiple Sites of Pulmonary Involvement -- 8.4.4.1 Multiple Primary Lung Cancers -- 8.4.4.2 Lung Cancer with One or More Tumor Nodules -- 8.4.4.3 Multiple Ground-glass Lesions -- 8.4.4.4 Consolidation -- 8.4.5 Tumor Measurement -- 8.4.6 Small Cell Lung Cancer -- 8.5 Concluding Remarks -- References -- 9: Diseases of the Chest Wall, Pleura, and Diaphragm -- 9.1 Introduction -- 9.2 Chest Wall Disease -- 9.3 Hyperlucent or Hyperopaque Hemithorax -- 9.4 Soft Tissue Masses -- 9.5 Inflammatory Disease of the Chest Wall.

9.6 Calcification -- 9.6.1 Pectus Excavatum -- 9.6.2 Injuries to the Thoracic Skeleton/Rib Fractures/Trauma -- 9.7 Thalassaemia -- 9.8 Pleural Disease -- 9.9 Pleural Effusion -- 9.10 Empyema -- 9.11 Pneumothorax -- 9.12 Hemothorax -- 9.13 Pleural Plaques or Thickening -- 9.14 Pleural Implants and Masses -- 9.15 Diaphragmatic Disease -- 9.16 Bochdalek Hernia -- 9.17 Morgagni Hernia -- 9.18 Diaphragmatic Eventration -- 9.19 Esophageal hiatus hernia -- 9.20 Blunt Traumatic Diaphragmatic Rupture -- 9.21 Penetrating Diaphragmatic Injury -- 9.22 Diaphragmatic Paresis or Paralysis -- 9.23 Tumors of the Diaphragm -- 9.24 Conclusion -- References -- 10: Pediatric Chest Disorders: Practical Imaging Approach to Diagnosis -- 10.1 Introduction -- 10.2 Advantages and Disadvantages of Imaging Modalities -- 10.2.1 Chest Radiography -- 10.2.2 Computed Tomography -- 10.2.3 Magnetic Resonance Imaging -- 10.3 Spectrum of Pediatric Thoracic Disorders -- 10.3.1 Pediatric Lung Disorders -- 10.3.1.1 Neonatal Lung Disorders -- Surfactant Deficiency Syndrome due to Prematurity -- Congenital Surfactant Deficiency -- Transient Tachypnea of Newborn -- Meconium Aspiration -- Neonatal Pneumonia -- 10.3.1.2 Pulmonary Infection in Children -- Round Pneumonia -- 10.3.2 Pediatric Large Airway Disorders -- 10.3.2.1 Large Airway Neoplasms -- Subglottic Hemangioma -- Carcinoid Tumor -- 10.3.2.2 Nonneoplastic Disorders of the Large Airway -- Tracheomalacia -- Foreign Body Aspiration -- 10.3.3 Pediatric Mediastinal Disorders -- 10.3.3.1 Vascular Lesions -- Double Aortic Arch -- Right Aortic Arch -- Pulmonary Artery Sling -- 10.3.3.2 Nonvascular Lesions -- Foregut Duplication Cyst -- Neuroblastoma -- Lymphatic Malformation -- 10.4 Conclusion -- References -- 11: Pulmonary Manifestations of Systemic Diseases -- 11.1 Introduction -- 11.2 Sarcoidosis.

11.3 Connective Tissue Disease.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2022. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

yorum yazmak için.

Ziyaretçi Sayısı

Destekleyen Koha